|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2008;136:1095-1097
© 2008 The American Association for Thoracic Surgery
Brief Communication |
a Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
b Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
c Department of Genetics, National Taiwan University Hospital, Taipei, Taiwan
Received for publication November 25, 2007; accepted for publication January 17, 2008. * Address for reprints: Shoei-Shen Wang, MD, PhD, Department of Surgery, National Taiwan University Hospital, 7 Chung-Shan S Rd, Taipei 100, Taiwan. (Email: sswang{at}ha.mc.ntu.edu.tw).
Barth syndrome, an X-linked recessive disorder, is caused by mutations in the taffazin gene (TAZ) at Xq28, leading to severe cardiolipin deficiency in the mitochondrial membrane.1
The most common presentation is cardiomyopathy in infancy, including left ventricular (LV) dilation, hypertrophy, and noncompaction, with congestive heart failure.
In the case of refractory heart failure, a heart transplant is considered to be required.2
We performed a successful mitral valve repair on an infant with Barth syndrome with a presentation of cardiogenic shock. We describe the techniques and consideration for mitral valve repair for this infant.
An 11-month-old boy had Barth syndrome, which had been diagnosed during his early infancy. Echocardiography revealed LV noncompaction with hypertrophy and impaired systolic function (LV ejection fraction 36%) with severe mitral regurgitation (MR). He was treated with furosemide, captopril, and aspirin. He was also on the waiting list for a heart transplant.
The patient was admitted to the intensive care unit with the impression of cardiogenic shock. Echocardiography showed severe MR with dilated left atrium and LV (
Figure 1, A). A short period of cardiac massage was required for profound shock and bradycardia; the cardiac surgeon was then immediately consulted regarding placement of a mechanical circulatory support bridge to transplant. We offered mitral valvoplasty as an alternative treatment, because donors for infant heart transplants is extremely rare in our country. Before surgery, the patient's heart rate was 170 beats/min, and his blood pressure was only 60/30 mm Hg, despite an infusion of dopamine (10 µg/[kg · min]) and milrinone (0.5 µg/[kg · min]). After cardiopulmonary bypass, the mitral valve was exposed through the dilated left atrium. We made a partial ring (
Figure 2) from an expanded polytetrafluoroethylene patch (GORE-TEX cardiovascular patch, 0.4-mm thickness; W.L. Gore & Associates, Inc, Flagstaff, Ariz) for reductive annuloplasty. The inner diameter was 16 mm, and the width was 2 mm. With interrupted 3-0 braided polyester suture (Ethibond; Ethicon, Inc, Somerville, NJ), the expanded polytetrafluoroethylene ring was fixed on the mitral annulus, except in the intertrigone region. The saline solution test confirmed no leakage after the procedure. The patient was smoothly weaned from cardiopulmonary bypass after a bypass time of 76 minutes and an aortic crossclamp time of 33 minutes.
|
|
To our knowledge, this is the first report of mitral valve surgery on an infant with Barth syndrome and severe heart failure. Although we found no data on mitral valve surgery in patients with genetic cardiomyopathy, mitral valve plasty is used as a surgical alternative to heart transplant in patients with ischemic or dilated cardiomyopathy. In this patient, although the LV ejection fraction remained about 35%, the left atrium and LV significantly decreased in size. This finding is consistent with the reverse remodeling of the LV that occurs after amelioration of MR.3
Planning of the mitral valve repair in this patient was based on echocardiographic findings. On long-axis views, the regurgitating jet came from noncoaptation of the anterior mitral leaflet (AML) and posterior mitral leaflet, the result of dilation of the annulus and tethering of the posterior mitral leaflet. The annular diameter was measured as 25 mm, and the AML length was 20 mm (Figure 1, A). Because the reduction annuloplasty did not correct the tethering of the posterior mitral leaflet but rather augmented it,4
we needed to make the AML the sole functioning leaflet with good coaptation height. We therefore decided on a final annular diameter of 16 mm, which would likely result in a zone of coaptation for the valve larger than 4 mm. Postoperative echocardiography confirmed our expectation; the AML was the sole functioning leaflet after the surgery.
A commercially produced pediatric annular ring was unavailable. Although some surgeons use a pericardial strip to make a mitral ring for adults,5
we used a GORE-TEX patch to form a ring, which we thought would both be a fixed length and preserve some flexibility.
In conclusion, we report our experience with mitral valve repair in an infant with Barth syndrome and severe MR. On the basis of echocardiographic assessment and with surgical planning, reductive mitral annuloplasty was able to be used as an alternative to a heart transplant for this infant with severe MR and heart failure of genetic cardiomyopathy.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |